Ausgabe 5/2016
Inhalt (12 Artikel)
Adenosine can thwart antitumor immune responses elicited by radiotherapy
Peter Vaupel, Gabriele Multhoff
Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy
Konrad Mohnike, Steffen Wolf, Robert Damm, Max Seidensticker, Ricarda Seidensticker, Frank Fischbach, Nils Peters, Peter Hass, Günther Gademann, Maciej Pech, Jens Ricke
Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer
Cesare Cozzarini, Tiziana Rancati, Fabio Badenchini, Federica Palorini, Barbara Avuzzi, Claudio Degli Esposti, Giuseppe Girelli, Ilaria Improta, Vittorio Vavassori, Riccardo Valdagni, Claudio Fiorino
Seed loss in prostate brachytherapy
Nancy El-Bared, Natanel Sebbag, Dominic Béliveau-Nadeau, Yannick Hervieux, Renée Larouche, Daniel Taussky, Guila Delouya
Towards clinical implementation of ultrafast combined kV-MV CBCT for IGRT of lung cancer
Anna Arns, Manuel Blessing, Jens Fleckenstein, Dzmitry Stsepankou, Judit Boda-Heggemann, Anna Simeonova-Chergou, Jürgen Hesser, Frank Lohr, Frederik Wenz, Hansjörg Wertz
4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma
Gabriele Reinartz, Uwe Haverkamp, Ramona Wullenkord, Philipp Lehrich, Jan Kriz, Florian Büther, Klaus Schäfers, Michael Schäfers, Hans Theodor Eich
Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique
Marzieh Bahrainy, Matthias Kretschmer, Vincent Jöst, Astrid Kasch, Florian Würschmidt, Jörg Dahle, Jörn Lorenzen
Radiation recall dermatitis induced by sorafenib
Sonja Stieb, Oliver Riesterer, Cornelia Brüssow, Bernhard Pestalozzi, Matthias Guckenberger, Stefan Weiler
Verzicht auf die adjuvante Radiotherapie beim duktalen Carcinoma in situ
David Krug, Rainer Souchon
Ist beim diffus großzelligen B‑Zell-Lymphom im frühen Stadium nach der Chemotherapie eine konsolidierende Strahlentherapie erforderlich?
Carsten Nieder